Access Bio, Inc. (KOSDAQ:950130)

Access Bio Revenue

In the year 2025, Access Bio had annual revenue of 31.26B KRW, down -72.21%. Access Bio had revenue of 5.23B in the quarter ending December 31, 2025, a decrease of -81.74%.

• Revenue: 31.26B
• Revenue Growth: -72.21%
• P/S Ratio: 3.92
• Revenue / Employee: 309.46M
• Employees: 101
• Market Cap: 122.58B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	31.26B	-81.21B	-72.21%
Dec 31, 2024	112.46B	-236.18B	-67.74%
Dec 31, 2023	348.64B	-685.22B	-66.28%
Dec 31, 2022	1.03T	528.75B	104.68%
Dec 31, 2021	505.11B	383.31B	314.71%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 28, 2026

Data Sources Report a data error